Quantcast
Last updated on April 18, 2014 at 12:48 EDT

Latest Artificial organs Stories

2011-11-10 13:10:00

VCU Medical Centerâs Retrospective Study Compares Patient Exercise Performance and Blood Pressure Response of the Total Artificial Heart vs. the HeartMate II LVAD Tucson, AZ (PRWEB) November 10, 2011 In the November issue of The Journal of Heart and Lung Transplantation (JHLT), Virginia Commonwealth University (VCU) Medical Center in Richmond published the first findings demonstrating that physical exercise and measurable rehabilitation are feasible with the SynCardia temporary...

2011-11-10 13:00:00

SARATOGA, Calif., Nov. 10, 2011 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced that the first patient has received the FDA-approved Implantable Miniature Telescope (by Dr. Isaac Lipshitz) procedure indicated to improve vision in patients with end-stage age-related macular degeneration (AMD). The first patient was evaluated by and received the telescope implant procedure from ophthalmologists Henry L. Hudson, M.D.,...

2011-11-03 07:30:00

PLEASANTON, Calif., Nov. 3, 2011 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today the enrollment of the first patient into the ROADMAP (Risk Assessment and Comparative Effectiveness Of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients) study. The patient was enrolled at INTEGRIS Baptist Medical Center in Oklahoma...

2011-09-21 09:15:00

TUCSON, Ariz., Sept. 21, 2011 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the SynCardia temporary Total Artificial Heart, announced today that University Hospital of Nantes successfully transplanted 51-year-old Total Artificial Heart patient Louise Mouche after 177 days of support. Mrs. Mouche is a French gypsy who lives with a sedentary group of people approximately 40 km from Nantes. "We first implanted Mrs. Mouche with a left ventricular assist device...

2011-09-20 07:00:00

PLEASANTON, Calif., Sept. 20, 2011 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Lazard Capital Markets 3rd Annual Circulatory Assist Device Day on Thursday, September 22. Taylor Harris, Senior Director of Investor Relations and Business Development, will provide an update on the company, beginning at 8:30 a.m., Eastern...

2011-09-13 10:30:00

VALENCIA, Calif., Sept. 13, 2011 /PRNewswire/ -- Advanced Bionics (AB), the only U.S.-based manufacturer of cochlear implants and a subsidiary of Switzerland-based Sonova, announced today the approval of the FDA for immediate market re-entry of the HiRes 90K cochlear implant in the United States. In recent months, Advanced Bionics received approval from several other regulatory agencies, including Health Canada and the European Notified Body, TUV, to resume distribution of the HiRes 90K...

2011-09-08 15:00:00

SARATOGA, Calif., Sept. 8, 2011 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced that the Centers for Medicare and Medicaid Services (CMS) has granted transitional pass-through payment status and established a billing code for the Implantable Miniature Telescope (IMT(TM) by Dr. Isaac Lipshitz) under the Hospital Outpatient Prospective Payment System. The new pass-through code, C1840, is effective October 1, 2011...

2011-08-03 07:00:00

HOUSTON, Aug. 3, 2011 /PRNewswire/ -- Texas Children's Hospital is the nation's first pediatric hospital to both surgically implant and later explant a mechanical ventricular assist device (VAD), inside the chest of a teen with chronic heart failure as a bridge to recovery, avoiding heart transplantation. The patient, 15-year-old David Rios, returned to his home in South Texas with a healed heart after spending seven months at Texas Children's Hospital recovering from a life-threatening...

2011-06-28 12:35:00

SAN DIEGO, June 28, 2011 /PRNewswire/ -- Results of a clinical research study at Sharp Memorial Hospital indicate that patients 70 years of age or older have good functional recovery,( )survival and quality of life at two years when undergoing left ventricular assist device (LVAD) therapy for heart failure. The study was released in the June 21 edition of the Journal of the American College of Cardiology. (Photo: http://photos.prnewswire.com/prnh/20110628/LA27443) The study's lead...

2011-06-13 13:01:08

The incidence of internal bleeding was higher in the most commonly implanted heart device than in an earlier model, according to two studies at Henry Ford Hospital in Detroit. The HeartMate II, a left ventricular assist device (LVAD) is a continuous-flow mechanical pump connected to the patient's heart that takes over the pumping of the weakened heart's left ventricle. "Although there were more instances of bleeding in the skull and gastrointestinal track with the HeartMate II, as opposed to...